Literature DB >> 16454526

Stability of serum-free and purified baculovirus stocks under various storage conditions.

Hasnaa Jorio1, Rosa Tran, Amine Kamen.   

Abstract

In a context of large-scale production of baculoviruses in serum-free media for use as gene delivery vectors, the stability of these viruses has become an important factor. The development of robust processes heavily relies on baculovirus stock stability. In the present work, we studied over a period of 300 days the stability of baculovirus vectors produced in serum-free media stored at 4, -20, or -80 degrees C or in liquid nitrogen. The viral stocks investigated were either crude baculovirus supernatant, baculovirus supernatant concentrated 10 times and diafiltered against fresh serum-free media by tangential flow filtration, or baculovirus purified by size exclusion chromatography. The results showed that baculovirus supernatant and diafiltered concentrate stored at 4 degrees C underwent a progressive loss of infectivity after a period of 100 and 50 days of storage, respectively. Aggregation has been recognized as the probable mechanism for the loss of infectivity. Baculovirus stocks were unstable at -20 degrees C, whereas in liquid nitrogen they retained infectivity after successive freeze thaw cycles. Concentration and diafiltration of baculovirus supernatant prior to storing at -80 degrees C contributed to improving viral stock stability over time. Glycerol as well as DMSO and sucrose have proven to be equally effective as additives to maintain the purified baculovirus stability after storage at -80 degrees C or in liquid nitrogen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454526     DOI: 10.1021/bp050218v

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  9 in total

1.  Evaluation of the Virus Counter® for rapid baculovirus quantitation.

Authors:  Matthew M Ferris; Patricia C Stepp; Kirk A Ranno; Wafaa Mahmoud; Elizabeth Ibbitson; James Jarvis; Manon M J Cox; Kurt Christensen; Heather Votaw; Dean P Edwards; Kathy L Rowlen
Journal:  J Virol Methods       Date:  2010-10-21       Impact factor: 2.014

2.  Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02- to 200-liter cultures.

Authors:  Sylvain Cecchini; Tamas Virag; Robert M Kotin
Journal:  Hum Gene Ther       Date:  2011-05-16       Impact factor: 5.695

3.  Aptamer-facilitated cryoprotection of viruses.

Authors:  Shahrokh M Ghobadloo; Ana Gargaun; Rebecca Casselman; Darija Muharemagic; Maxim V Berezovski
Journal:  ACS Med Chem Lett       Date:  2014-09-23       Impact factor: 4.345

4.  Membrane Protein Production and Purification from Escherichia coli and Sf9 Insect Cells.

Authors:  Yixin Liu; Ana Pavić; Joshua T Farley; Carine de Marcos Lousa; Adrian Goldman; Vincent L G Postis
Journal:  Methods Mol Biol       Date:  2020

5.  Production and Use of Gesicles for Nucleic Acid Delivery.

Authors:  Mathias Mangion; Marc-André Robert; Igor Slivac; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2021-10-01       Impact factor: 2.695

6.  Overexpression and purification of Dicer and accessory proteins for biochemical and structural studies.

Authors:  Niladri K Sinha; Brenda L Bass
Journal:  Methods       Date:  2017-07-16       Impact factor: 3.608

7.  Using cell size kinetics to determine optimal harvest time for Spodoptera frugiperda and Trichoplusia ni BTI-TN-5B1-4 cells infected with a baculovirus expression vector system expressing enhanced green fluorescent protein.

Authors:  Laura Sander; Anna Harrysson
Journal:  Cytotechnology       Date:  2007-04-14       Impact factor: 2.058

Review 8.  Manufacturing of AcMNPV baculovirus vectors to enable gene therapy trials.

Authors:  Timothy Weixin Kwang; Xinhui Zeng; Shu Wang
Journal:  Mol Ther Methods Clin Dev       Date:  2016-01-27       Impact factor: 6.698

9.  Evaluation of screening platforms for virus-like particle production with the baculovirus expression vector system in insect cells.

Authors:  Florian Strobl; Sahar Masoumeh Ghorbanpour; Dieter Palmberger; Gerald Striedner
Journal:  Sci Rep       Date:  2020-01-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.